Lumida
/BWIN
⌘K
Baldwin Insurance Group Inc

Baldwin Insurance Group Inc

BWIN
$27.25USD↓-0.91%-0.25 today

MARKET CAP

3.9B

P/E (TTM)

16.3x

FWD P/E

11.3x

DAY RANGE

$27 – $29

52W RANGE

$16
$44

AI Summary

Stalk
Buy NowHigh

BWIN is in a Stage 2 advancing phase with medium-term bullish bias underpinned by a Lockout Rally pattern and a clear higher-high/lower-high sequence above rising EMAs. Price pulls back into rising 9EMA, 20EMA, and the rising 50DMA with healthy volume and no exhaustion, presenting favorable execution conditions for continuation. Despite overbought momentum signals and a long-term downtrend under the declining 200DMA, the active Lockout Rally override justifies immediate entry on pullbacks into the EMAs.

  • ↑Q1 revenue of $532M (+2% YoY) boosted by 27% partnership contributions.
  • ↑Projected AI-driven productivity gains of up to 80% to cut costs.
  • ↓Adjusted EBITDA margin fell to 25.8%, highlighting low conversion efficiency.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

The Baldwin Insurance Group Inc. (NASDAQ:BWIN) is a growing player in the insurance advisory and underwriting sector, focusing on offering integrated solutions for both personal and commercial insurance lines. With a strategy aimed at leveraging advanced technology and partnerships, such as their recent collaboration with Anthropic on AI integration, Baldwin positions itself to navigate disruptions within the industry. This strategic positioning against a backdrop of macroeconomic uncertainty, competition in both traditional and embedded insurance markets, and regulatory challenges shapes the value proposition for investors.

Bull says

  • ↑Q1 revenue of $532M (+2% YoY) boosted by 27% partnership contributions.
  • ↑Projected AI-driven productivity gains of up to 80% to cut costs.
  • ↑$250M buyback approved, $50M executed at ~8× EBITDA to enhance value.
  • ↑94% customer retention in Vanguard Producers supports stable revenues.
  • ↑Q2 guide at $485–495M; organic growth inflection expected H2 2026.
  • ↑High earnings yield (1.07), strong growth factors and positive revisions underpin valuation.

Bear says

  • ↓Adjusted EBITDA margin fell to 25.8%, highlighting low conversion efficiency.
  • ↓Negative stock momentum reflects declining investor confidence in recovery.
  • ↓Property pricing back to 2017 levels; Medicare segment headwinds persist.
  • ↓High short interest and mixed insider activity underscore bearish sentiment.
  • ↓Net leverage of 4.3× may constrain flexibility amid market softness.
  • ↓Organic revenue growth at 2% may lag expectations and delay recovery.

Investment themes with BWIN

Most Shorted Stocks↑ +0.88%

Stocks with highest short interest

LITE · AXTI · NVTS

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 05-22-2026neutral

Transcript signals

Bull points

  • In the first quarter, we generated organic revenue growth and adjusted EBITDA growth of 10% and 12%, respectively, while delivering 80 basis points of adjusted EBITDA margin improvement and 16% growth in adjusted diluted earnings per share.
  • overall organic revenue growth for the quarter was 3%
  • In April, we announced the finalization of our third-party-led capitalization of our inaugural reciprocal insurance exchange named Builder Reciprocal Insurance Exchange or BRII for short, to support continued growth in our builder channel. As of today, we have closed on the $110 million capitalization of the reciprocal and will imminently begin migrating the builder book.

Bear points

  • greater macroeconomic uncertainty and what that may mean relative to client business activity
  • the largest driver of potential economic headwinds on the 6-1 renewals for us are around the quota share reinsurance capacity, which is still somewhat supply constrained in the markets
  • while the headline organic print for the quarter was below our historic results, this was not unexpected, as we called out the expectation for single-digit organic growth this quarter on our year-end call.
Read full transcript analysis ›